CIK 0000728387 · Non-accelerated filer<br>Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411458152
- Phone
- 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- Open-market buys, last 90 days
- $37,943
- in 1 filing
- Open-market sales, last 90 days
- $1,622,534
- in 5 filings
Net −$1,584,591. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-09 | Austin Mark John VP Finance/Prin Fin&Acct Offic | Grant or award · Stock Options (right to buy) | +150,000 | 548,115 | ||
| 2022-08-05 | Streeter Jennifer COO & VP of HR | Option exercise | +22,500 | $0.33 | $7K | 27,940 |
| 2022-08-05 | Streeter Jennifer COO & VP of HR | Option exercise · Stock Options (right to buy) | −22,500 | 0 | ||
| 2022-07-21 | Cavanagh William Chief R&D Officer | Grant or award · Stock Options (right to buy) | +475,000 | 1,493,846 | ||
| 2022-07-21 | McCormick Michael W Director | Grant or award · Stock Options (right to buy) | +135,000 | 424,615 | ||
| 2022-07-21 | Hunt Jonathan Robert Chief Financial Officer | Grant or award · Stock Options (right to buy) | +475,000 | 1,278,653 | ||
| 2022-07-21 | Woods Lori A CEO | Grant or award · Stock Options (right to buy) | +940,000 | 1,670,000 | ||
| 2022-07-21 | Streeter Jennifer COO & VP of HR | Grant or award · Stock Options (right to buy) | +475,000 | 1,295,000 | ||
| 2022-07-21 | Vitale Philip J Director | Grant or award · Stock Options (right to buy) | +135,000 | 425,000 | ||
| 2022-07-21 | Hoffmann Alan Director | Grant or award · Stock Options (right to buy) | +135,000 | 424,615 | ||
| 2022-06-09 | Austin Mark John VP Finance/Prin Fin&Acct Offic | Purchase | +13,800 | $0.29 | $4K | 54,030 |
| 2022-06-08 | Austin Mark John VP Finance/Prin Fin&Acct Offic | Purchase | +5,000 | $0.29 | $1K | 40,230 |
| 2022-06-08 | Hunt Jonathan Robert Chief Financial Officer | Purchase | +25,675 | $0.29 | $7K | 106,306 |
| 2022-06-07 | Woods Lori A CEO | Purchase | +75,000 | $0.30 | $22K | 1,047,038 |
| 2022-06-07 | Hunt Jonathan Robert Chief Financial Officer | Purchase | +13,325 | $0.28 | $4K | 80,631 |
| 2021-11-23 | Woods Lori A CEO | Option exercise | +62,500 | $0.46 | $29K | 909,538 |
| 2021-11-23 | Woods Lori A CEO | Option exercise | +62,500 | $0.43 | $27K | 972,038 |
| 2021-11-23 | Woods Lori A CEO | Option exercise · Stock Options (right to buy) | −62,500 | 0 | ||
| 2021-11-23 | Woods Lori A CEO | Option exercise · Stock Options (right to buy) | −62,500 | 62,500 | ||
| 2021-07-01 | Cavanagh William Chief R&D Officer | Grant or award · Stock Options (right to buy) | +320,000 | 1,025,506 |
Page 7 of 26 · 502 trades